VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
IBRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
IBRXImmunityBio, Inc.
$8.91$9.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksIBRXQuarterly Financials

ImmunityBio, Inc. (IBRX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

ImmunityBio, Inc. (IBRX) quarterly income statement — complete revenue, gross profit & net income history

IBRX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue44.21M38.28M32.06M26.43M16.52M7.55M6.11M1.05M40K139K82K41K360K73K118K35K14K390K66K339K
Revenue Growth %167.64%406.95%425.07%2423.88%41192.5%5333.09%7346.34%2453.66%-88.89%90.41%-30.51%17.14%2471.43%-81.28%78.79%-89.68%-89.93%1757.14%-56.29%-22.25%
Cost of Goods Sold238K4.25M4.13M136K58K00000006.28M6.88M5.97M5.93M5.41M000
COGS % of Revenue0.54%11.09%12.88%0.51%0.35%-------1743.89%9421.92%5063.56%16945.71%38628.57%---
Gross Profit43.97M34.04M27.93M26.29M16.46M7.55M6.11M1.05M40K139K82K41K-5.92M-6.8M-5.86M-5.9M-5.39M390K66K339K
Gross Margin %99.46%88.91%87.12%99.49%99.65%100%100%100%100%100%100%100%-1643.89%-9321.92%-4963.56%-16845.71%-38528.57%100%100%100%
Gross Profit Growth %167.14%350.72%357.47%2410.89%41047.5%5333.09%7346.34%2453.66%100.68%102.04%101.4%100.7%-9.71%-1844.87%-8974.24%-1839.23%-3980.58%117.52%-56.29%-22.25%
Operating Expenses113.76M98.72M83.56M97.57M80.89M76.95M86.36M100.38M95.24M85.53M80.22M85.19M105.66M77.41M84.95M73.73M90.58M79.66M78.9M86.25M
OpEx % of Revenue257.34%257.86%260.64%369.25%489.73%1018.96%1414.33%9587.39%238090%61530.94%97826.83%207770.73%29350.56%106046.58%71988.98%210645.71%646985.71%20426.67%119548.48%25441%
Selling, General & Admin44.46M37.83M32.83M42.34M32.65M41.73M35.92M49.25M41.88M33.11M31.82M32.02M26.9M24.56M17.84M15.09M39.29M27.91M29.63M32.45M
SG&A % of Revenue100.58%98.82%102.4%160.22%197.7%552.58%588.21%4704.01%104712.5%23820.14%38800%78092.68%7471.67%33647.95%15114.41%43108.57%280642.86%7156.67%44886.36%9570.8%
Research & Development64.77M60.81M50.73M55.24M48.23M35.22M50.44M51.13M53.35M51.53M48.4M53.17M78.76M52.85M67.11M58.64M51.29M51.75M49.28M53.8M
R&D % of Revenue146.52%158.83%158.24%209.03%292.03%466.38%826.12%4883.38%133377.5%37073.38%59026.83%129678.05%21878.89%72398.63%56874.58%167537.14%366342.86%13270%74662.12%15870.21%
Other Operating Expenses1000K00000000886K0000000-59K-38K0
Operating Income-69.79M-64.68M-55.63M-71.28M-64.43M-69.4M-80.25M-99.33M-95.2M-85.39M-80.14M-85.14M-111.58M-84.22M-90.8M-79.62M-95.97M-79.27M-78.84M-85.91M
Operating Margin %-157.88%-168.95%-173.51%-269.76%-390.08%-918.96%-1314.33%-9487.39%-237990%-61430.94%-97726.83%-207670.73%-30994.44%-115368.49%-76952.54%-227491.43%-685514.29%-20326.67%-119448.48%-25341%
Operating Income Growth %-8.32%6.8%30.68%28.24%32.32%18.72%-0.15%-16.66%14.68%-1.39%11.75%-6.94%-16.26%-6.24%-15.18%7.32%-11.25%-156.67%-19.67%-68.72%
EBITDA-65.41M-60.82M-51.68M-67.41M-60.6M-65.25M-75.81M-94.93M-90.64M-80.83M-75.6M-80.46M-105.3M-77.34M-84.83M-73.69M-90.56M-74.3M-73.92M-81.92M
EBITDA Margin %-147.97%-158.86%-161.19%-255.08%-366.89%-863.96%-1241.63%-9066.57%-226602.5%-58147.48%-92193.9%-196251.22%-29250.56%-105946.58%-71888.98%-210545.71%-646885.71%-19050%-111996.97%-24165.78%
EBITDA Growth %-7.94%6.79%31.83%28.99%33.14%19.28%-0.28%-17.98%13.92%-4.5%10.88%-9.19%-16.27%-4.1%-14.76%10.05%-10.8%-159.42%-18.6%-72.77%
D&A (Non-Cash Add-back)4.38M3.87M3.95M3.88M3.83M4.15M4.44M4.41M4.55M4.56M4.54M4.68M6.28M6.88M5.97M5.93M5.41M4.98M4.92M3.98M
EBIT-69.79M-34.9M-39.73M-63.42M-101.03M-44.27M-45.51M-95.56M-102.19M-201.33M-60.62M-105.98M-87.03M-79.76M-94.39M-84.68M-93.46M-87.06M-84.81M-85.81M
Net Interest Income-26.14M-23.93M-25.49M-28.07M-28.34M-14.14M-39.61M-38.19M-35.06M-30.28M-34.41M-31.64M-29.27M-28.05M-16.51M-9.05M-7.2M-4.21M-3.51M-3.46M
Interest Income2.32M3.26M2.1M818K520K769K638K833K2.42M1.84M610K592K284K515K253K644K1.3M284K101K112K
Interest Expense28.46M27.19M27.58M28.88M28.86M14.9M40.25M39.02M37.49M32.13M35.02M32.23M29.56M28.56M16.76M9.7M8.49M4.49M3.61M3.58M
Other Income/Expense-563M2.59M-11.68M-21.02M-65.47M10.22M-5.5M-35.25M-38.93M-148.06M-15.51M-53.07M-5M-24.07M-20.36M-15.21M-7.03M-12.28M-9.59M-3.48M
Pretax Income-632.79M-62.09M-67.31M-92.31M-129.9M-59.18M-85.75M-134.58M-134.13M-233.45M-95.64M-138.21M-116.58M-108.29M-111.16M-94.83M-103M-91.55M-88.43M-89.38M
Pretax Margin %-1431.46%-162.19%-209.94%-349.31%-786.46%-783.62%-1404.39%-12854.25%-335325%-167952.52%-116636.59%-337104.88%-32384.17%-148345.21%-94204.24%-270957.14%-735700%-23474.87%-133983.33%-26366.67%
Income Tax-9K-135K-35K269K-234K0000-40K00034K0001K02K
Effective Tax Rate %0%0.22%0.05%-0.29%0.18%0%0%0%0%0.02%0%0%0%-0.03%0%0%0%-0%0%-0%
Net Income-632.78M-61.94M-67.25M-92.56M-129.65M-59.16M-85.73M-134.56M-134.11M-233.39M-95.58M-137.88M-116.34M-108.22M-110.94M-94.59M-102.83M-91.26M-87.63M-88.29M
Net Margin %-1431.44%-161.8%-209.77%-350.26%-784.92%-783.4%-1404.01%-12852.34%-335272.5%-167907.91%-116563.41%-336290.24%-32317.5%-148239.73%-94015.25%-270251.43%-734471.43%-23399.74%-132771.21%-26043.66%
Net Income Growth %-388.08%-4.7%21.55%31.22%3.33%74.65%10.31%2.4%-15.27%-115.67%13.84%-45.77%-13.15%-18.58%-26.6%-7.14%-29.16%-184.01%-33.57%-71.64%
Net Income (Continuing)-632.78M-61.96M-67.27M-92.57M-129.67M-59.18M-85.75M-134.58M-134.13M-233.41M-95.64M-138.21M-116.58M-108.33M-111.16M-94.83M-103M-91.55M-88.43M-89.39M
Discontinued Operations00000000000000000000
Minority Interest880K895K909K930K949K969K986K1.01M1.03M1.05M1.07M-3.07M-2.73M-2.49M-2.38M-2.16M-1.91M-1.74M-1.45M-646K
EPS (Diluted)-0.62-0.06-0.07-0.10-0.15-0.09-0.12-0.20-0.20-0.40-0.19-0.32-0.35-0.27-0.28-0.24-0.26-0.23-0.22-0.23
EPS Growth %-313.33%30.44%40.83%50%25%77.5%36.84%37.5%42.86%-48.15%32.14%-33.33%-34.62%-17.39%-27.27%-4.35%-23.81%-27.78%-29.41%-76.92%
EPS (Basic)-0.62-0.06-0.07-0.10-0.15-0.08-0.12-0.20-0.20-0.40-0.19-0.32-0.35-0.27-0.28-0.24-0.26-0.23-0.22-0.23
Diluted Shares Outstanding1.03B989.68M946.6M888.22M853.16M734.54M697.96M686.94M672.83M590.73M498.38M437.46M428.38M403.64M400.06M397.99M397.88M397.12M391.85M384.82M
Basic Shares Outstanding1.03B989.68M946.6M888.22M853.16M733.2M695.89M686.94M672.83M590.73M498.38M437.46M428.38M403.64M400.06M397.99M397.88M397.12M391.85M384.82M
Dividend Payout Ratio--------------------